Details for Patent: 9,265,893

✉ Email this page to a colleague

Which drugs does patent 9,265,893 protect, and when does it expire?

Patent 9,265,893 protects VICTOZA and is included in one NDA.

Protection for VICTOZA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifteen patent family members in thirteen countries.

Summary for Patent: 9,265,893

Title:	Injection button
Abstract:	A push button connection for an injection device comprising a push button (10) and a driving part (20). The two parts of the push button connection are mounted to each other and is relatively rotatable to each other. In order to minimize the friction occurring between the push button and the driving part when relatively rotated forces are transmitted via a pivot bearing (18, 22). In order also to minimize the effect of forces appearing dislocated from the center line a number of radial bearings (13, 23; 14, 25) having a little friction diameter is provided.
Inventor(s):	Hansen; Torben Stroem (Copenhagen V, DK), Wielandt; Jakob Oest (Copenhagen N, DK), Groth; Lars Moerch (Fredensborg, DK)
Assignee:	Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:	12/525,976
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,265,893
Patent Claim Types: see list of patent claims	Device;

Drugs Protected by US Patent 9,265,893

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novo Nordisk Inc	VICTOZA	liraglutide	SOLUTION;SUBCUTANEOUS	022341-001	Jan 25, 2010		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up			Y		⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,265,893

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	07101729	Feb 5, 2007

PCT Information
PCT Filed	January 21, 2008	PCT Application Number:	PCT/EP2008/050624
PCT Publication Date:	August 14, 2008	PCT Publication Number:	WO2008/095762

International Family Members for US Patent 9,265,893

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E483487	⤷ Sign Up
Australia	2008213084	⤷ Sign Up
Brazil	PI0806854	⤷ Sign Up
Canada	2676810	⤷ Sign Up
China	101605569	⤷ Sign Up
Germany	602008002896	⤷ Sign Up
Denmark	2109474	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.